Visit COVID-19 resources

[Skip to Content]

Uncategorised

COVID-19 Vaccination and second doses – Academy statement

Jan 19
2021

We are republishing the statement from the Academy of Medical Royal Colleges on the COVID-19 Vaccination and second doses. Read the full statement below: The Academy of Medical Royal Colleges firmly supports the decision of the four UK chief medical officers to prioritise the delivery of the first COVID-19 vaccine dose, and to delay the

  • 19 January 2021

Letter from clinical leaders

Jan 19
2021

There are many weeks ahead that are likely to be among the most challenging of all our professional lives. Doctors will be faced with many professional dilemmas and some may be pushed to the limits of physical and mental endurance. Please look after your colleagues – protracted, relentless crises are often much more draining than

  • 19 January 2021

Extra date for the OPT Training The Trainers programme

Dec 16
2020

The College is pleased to announce that an extra date has been added to the Spring 2021 OPT Training The Trainers programme and will be available to book shortly: OPT TTT – Friday 23 April 2021 (online, full day) Learning outcomes These courses are suitable for Ophthalmologists, Orthoptists, Optometrists and Ophthalmic Nurses who are experienced

  • 16 December 2020

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring

Dec 16
2020

Updated Guidelines December 2020 Following the publication of the RCOphth recommendations for monitoring in hydroxychloroquine and chloroquine users in 2018, new published evidence prompted a review of the guideline. Recent data have highlighted that hydroxychloroquine retinopathy is more common than previously reported. The prevalence in long-term users appears to be around 7.5% and depending on

  • 16 December 2020

The British Ophthalmological Surveillance Unit restart

Dec 03
2020

After a six month break, The British Ophthalmological Surveillance Unit has restarted case ascertainment from November 2020, recommencing the yellow card reporting system with the five studies that were already running. BOSU: Current Studies on the Yellow Card Study Lead investigator Hydroxychloroquine Retinopathy Imran Yusuf, Oxford Unexplained visual loss following removal of silicone oil Jonathan

  • 3 December 2020